22 completed, 2 terminated, 1 unknown. 10 Phase 2, 7 Phase 3, 4 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 9, Terminated 1 |
| Phase 3 | 7 | Completed 7 |
| Phase 4 | 4 | Completed 2, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Graceway Pharmaceuticals, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm - Actinic Keratosis | Phase 4 | Unknown | Frankel, Amylynne, M.D. | 20 | 2010-10-01 | 2011-06-22 |
| Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy Photodynamic therapy, Imiquimod - Actinic Keratosis | Phase 4 | Terminated | Tennessee Clinical Research Center | 21 | 2010-09-01 | 2014-12-08 |
| Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis GW05, Metronidazole - Vaginosis, Bacterial, Vaginal Infection | Phase 2 | Completed | Graceway Pharmaceuticals, LLC | 255 | 2010-01-01 | 2011-07-01 |
| Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery imiquimod cream, placebo cream - Actinic Keratosis | Phase 3 | Completed | Graceway Pharmaceuticals, LLC | 247 | 2009-05-01 | 2010-08-31 |
| The Effects of Aldara as an Adjunct to Laser Treatment Imiquimod, non-medicated petroleum cream - Port Wine Stains | Phase 2 | Terminated | Henry Vasconez | 7 | 2008-10-01 | 2018-03-22 |
| Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts 2.5% imiquimod cream, 3.75% imiquimod cream, Placebo cream - Genital Warts | Phase 3 | Completed | Graceway Pharmaceuticals, LLC | 511 | 2008-08-01 | 2011-07-20 |
| Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts Imiquimod, 3.75% imiquimod cream, placebo cream - Genital Warts | Phase 3 | Completed | Graceway Pharmaceuticals, LLC | 470 | 2008-05-01 | 2011-05-24 |
| Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year Actinic Keratoses | Completed | Graceway Pharmaceuticals, LLC | 179 | 2008-04-01 | 2010-07-20 | |
| Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal 1064 nm Nd:YAG laser, Imiquimod, 5% cream - Healthy | Phase 1 | Completed | University of Miami | 3 | 2008-02-01 | 2018-03-22 |
| Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs) Imiquimod cream, Placebo cream - Actinic Keratosis | Phase 3 | Completed | Graceway Pharmaceuticals, LLC | 490 | 2008-01-01 | 2010-06-29 |
| Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs) imiquimod cream, Placebo - Actinic Keratoses | Phase 3 | Completed | Graceway Pharmaceuticals, LLC | 479 | 2008-01-01 | 2010-06-29 |
| Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis imiquimod cream - Keratosis | Phase 4 | Completed | Graceway Pharmaceuticals, LLC | 551 | 2005-06-01 | 2010-07-20 |
| A Study to Validate Cosmetic Outcome Scales Used to Rate Uneven Skin Color and Wrinkling Skin Wrinkling | Completed | Graceway Pharmaceuticals, LLC | 48 | 2005-06-01 | 2007-02-19 | |
| Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands Aldara (imiquimod) cream, 5% - Keratosis | Phase 4 | Completed | Graceway Pharmaceuticals, LLC | 270 | 2005-05-01 | 2007-02-19 |
| Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects Resiquimod - Warts | Phase 2 | Completed | Graceway Pharmaceuticals, LLC | 84 | 2005-03-01 | 2007-02-19 |
| An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects Resiquimod - Warts | Phase 2 | Completed | Graceway Pharmaceuticals, LLC | 84 | 2005-03-01 | 2007-02-19 |
| A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy Imiquimod 5% cream - Hemangioma, Capillary | Phase 2 | Completed | St. Justine's Hospital | 18 | 2005-03-01 | 2008-01-25 |
| 1-Year Follow up to the 1473-IMIQ Study Imiquimod 5% cream - Keratosis | Completed | Graceway Pharmaceuticals, LLC | 84 | 2005-01-01 | 2007-02-19 | |
| Study With a Topical Gel to Treat Common Warts in Adults Resiquimod - Warts | Phase 2 | Completed | Graceway Pharmaceuticals, LLC | 48 | 2004-10-01 | 2007-02-19 |
| Study With a Topical Gel to Treat Common Warts in Adults Resiquimod - Warts | Phase 2 | Completed | Graceway Pharmaceuticals, LLC | 88 | 2004-08-01 | 2007-02-19 |
Showing 20 of 25. Sign in to see all of them.
Keratosis, Actinic (10) · Warts (6) · Keratosis (4) · Skin Diseases (4) · Condylomata Acuminata (2) · Hemangioma, Capillary (2) · Carcinoma, Basal Cell (1) · Hemangioma (1) · Pigmentation Disorders (1) · Vaginal Discharge (1) · Vaginal Diseases (1) · Vaginitis (1) · Vaginosis, Bacterial (1)
Imiquimod (12) · resiquimod (6) · Aminolevulinic Acid (1) · Cryotherapy (1) · Metronidazole (1) · Photochemotherapy (1) · Solutions (1)
United States (21) · Canada (2) · Australia (1) · New Zealand (1)
Sharon F Levy, MD (3) · Sharon Levy, MD (3) · Jason Wu, MD (2) · Catherine McCuaig, M.D. (1) · Gary S Goldenberg, MD (1) · Girish Munavalli, MD (1) · Henry C. Vasconez, MD (1) · Jim Lee, Dr. (1) · Joel Cohen, MD (1) · Keyvan Nouri, MD (1) · Michael Gold, MD (1) · TC Meng, MD (1) · Tania J Phillips, M.D. (1)
PMID 17034468, PMID 19419474, PMID 19597914, PMID 20133013, PMID 20666194, PMID 20729935, PMID 21283921, PMID 24983350